Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 4,420.00
-210.00 (-4.54%)
At close: Feb 6, 2026
Genexine Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Revenue | 5,808 | 4,427 | 16,139 | 36,828 | 18,543 | 11,303 |
Other Revenue | - | - | -0 | - | - | 0 |
| 5,808 | 4,427 | 16,139 | 36,828 | 18,543 | 11,303 | |
Revenue Growth (YoY) | -3.50% | -72.57% | -56.18% | 98.61% | 64.06% | 80.80% |
Cost of Revenue | 6,005 | 4,125 | 4,891 | 6,085 | 8,784 | 4,604 |
Gross Profit | -196.75 | 302.04 | 11,248 | 30,743 | 9,759 | 6,699 |
Selling, General & Admin | 14,953 | 15,879 | 13,351 | 10,131 | 8,016 | 9,116 |
Research & Development | 26,548 | 26,330 | 26,445 | 33,118 | 39,206 | 40,449 |
Amortization of Goodwill & Intangibles | 139.21 | 157.93 | 212.47 | 249.54 | 280.46 | 273.78 |
Other Operating Expenses | 1,858 | 316.5 | 974.58 | 5,031 | 706.48 | 809.37 |
Operating Expenses | 42,987 | 42,230 | 44,928 | 49,843 | 48,911 | 51,272 |
Operating Income | -43,184 | -41,928 | -33,680 | -19,099 | -39,151 | -44,573 |
Interest Expense | -3,791 | -4,111 | -3,810 | -699.63 | -2,922 | -4,585 |
Interest & Investment Income | 1,391 | 1,264 | 243.37 | 219.15 | 252.41 | 1,170 |
Earnings From Equity Investments | -479.33 | -16,840 | -50,131 | -21,474 | 44,271 | 30,744 |
Currency Exchange Gain (Loss) | 103.48 | 208.14 | 279.12 | 315.43 | -495.57 | 162.29 |
Other Non Operating Income (Expenses) | -1,338 | 1,637 | -239.68 | -2,898 | 17,866 | 853.11 |
EBT Excluding Unusual Items | -47,298 | -59,770 | -87,338 | -43,636 | 19,821 | -16,229 |
Gain (Loss) on Sale of Investments | 2,958 | 2,691 | 28.14 | 190.72 | 6,271 | 2,397 |
Gain (Loss) on Sale of Assets | -539.24 | -262.23 | 32,096 | -2,604 | 8,818 | 815.22 |
Asset Writedown | -8,511 | -8,401 | -1,599 | -2,827 | -1,712 | -3,493 |
Other Unusual Items | -1,118 | -1,118 | -18.43 | - | -5,662 | - |
Pretax Income | -54,508 | -66,860 | -56,831 | -48,876 | 27,536 | -16,509 |
Earnings From Continuing Operations | -54,508 | -66,860 | -56,831 | -48,876 | 27,536 | -16,509 |
Minority Interest in Earnings | -17.36 | -13.22 | 857.24 | 834.48 | 33.83 | - |
Net Income | -54,525 | -66,874 | -55,974 | -48,042 | 27,570 | -16,509 |
Net Income to Common | -54,525 | -66,874 | -55,974 | -48,042 | 27,570 | -16,509 |
Shares Outstanding (Basic) | 41 | 40 | 33 | 32 | 31 | 28 |
Shares Outstanding (Diluted) | 41 | 40 | 33 | 32 | 32 | 28 |
Shares Change (YoY) | 21.23% | 24.01% | 0.73% | 2.14% | 14.41% | 103.15% |
EPS (Basic) | -1320.62 | -1652.14 | -1714.88 | -1482.55 | 883.81 | -595.37 |
EPS (Diluted) | -1320.62 | -1652.14 | -1715.00 | -1482.55 | 671.51 | -595.38 |
Free Cash Flow | -42,303 | -45,328 | -71,547 | -69,178 | -44,899 | -45,533 |
Free Cash Flow Per Share | -1024.59 | -1119.84 | -2191.99 | -2134.81 | -1415.22 | -1642.07 |
Gross Margin | -3.39% | 6.82% | 69.69% | 83.48% | 52.63% | 59.27% |
Operating Margin | -743.54% | -947.19% | -208.69% | -51.86% | -211.13% | -394.34% |
Profit Margin | -938.81% | -1510.71% | -346.82% | -130.45% | 148.68% | -146.06% |
Free Cash Flow Margin | -728.36% | -1023.98% | -443.31% | -187.84% | -242.13% | -402.84% |
EBITDA | -38,135 | -36,897 | -28,808 | -15,801 | -36,231 | -42,070 |
EBITDA Margin | - | - | -178.50% | -42.90% | -195.38% | - |
D&A For EBITDA | 5,049 | 5,031 | 4,872 | 3,298 | 2,920 | 2,503 |
EBIT | -43,184 | -41,928 | -33,680 | -19,099 | -39,151 | -44,573 |
EBIT Margin | - | - | -208.69% | -51.86% | -211.13% | - |
Updated May 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.